Melleva

Ethinylestradiol, the active ingredient in Melleva, is a combined oral contraceptive presented as a tablet for oral use. It works together with levonorgestrel to prevent pregnancy and to help regulate menstrual cycles in women of reproductive age.

GNH USA supplies Melleva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU quality standards and providing reliable global distribution.

Melleva is a combined oral contraceptive that acts on the hormonal regulation of the menstrual cycle.

Contraception: Prevents pregnancy by suppressing ovulation, thickening cervical mucus, and altering the endometrium. Regulation of menstrual cycles: Provides cycle control and reduces irregular bleeding. Premenstrual syndrome (PMS) symptom relief: May lessen mood swings, bloating, and breast tenderness associated with the luteal phase.

Melleva may cause a range of adverse reactions. Patients should be aware of both frequent and rare events.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like. - Breast tenderness: temporary swelling or soreness. - Spotting or breakthrough bleeding: irregular light bleeding. - Mood changes: irritability or mild depressive symptoms. - Weight gain: modest increase in body weight.

Serious or Rare Side Effects: - Deep vein thrombosis: blood clot formation in the legs. - Pulmonary embolism: clot migration to the lungs. - Stroke: cerebrovascular accident due to clot or hemorrhage. - Hepatic adenoma: benign liver tumor. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Visual disturbances: sudden loss of vision or blurred sight.

Before prescribing Melleva, clinicians should evaluate patient history and risk factors. - Contraindicated in women with a history of thromboembolic disorders: avoid use. - Caution in smokers over 35 years old: increased cardiovascular risk. - Monitor liver function in patients with hepatic disease: adjust therapy as needed. - Assess for migraine with aura: consider alternative contraception. - Store at ambient temperature below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Melleva can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): may reduce contraceptive effectiveness. - Certain antiepileptic drugs (e.g., carbamazepine, phenytoin): increase hormone metabolism. - Rifampicin or other strong enzyme inducers: lower plasma hormone levels.

Moderate Interactions (Monitor Closely): - Antifungal agents (e.g., ketoconazole): may increase hormone concentrations. - St. John’s wort: may modestly reduce contraceptive efficacy.